Sebastian Porsdam Mann

Sebastian Porsdam Mann is an Assistant Professor at the Center for Advanced Studies in Bioscience Innovation Law within the Faculty of Law at the University of Copenhagen. His interdisciplinary work bridges philosophy, neuroscience, applied ethics, and international human rights law to examine how emerging technologies can advance scientific progress while respecting ethical and legal frameworks.

His academic credentials include:

• BA (Hons) from University of Cambridge (2013)
• PhD in Ethical Aspects of Novel Developments in Neuroscience from University of Cambridge (2017)
• Graduate Diploma in Law from BPP University (2021)
• DPhil in The Orphan of Time: A History and Theory of the Right to Science from University of Oxford (pending)

Prior to his current position, he held postdoctoral appointments at Harvard Medical School and the Universities of Oxford and Copenhagen, with the latter supported by a Carlsberg Foundation personal grant. His research focuses on the practical applications and regulatory conditions for novel technologies like blockchain and generative AI to facilitate scientific progress and uphold the human right to science.

His scholarly contributions include co-authoring/editing The Right to Science: Then and Now (Cambridge University Press, 2021) and Scientific Freedom: The Heart of the Right to Science (Rowman & Littlefield, 2023). His work on fine-tuning large language models for academic enhancement ('AUTOGEN') ranks as the most read article in the American Journal of Bioethics, the premier journal in bioethics.

His recent publications demonstrate a concentrated focus on applying AI technologies to healthcare challenges, particularly examining how generative AI can transform informed consent processes, clinical trial design, and biobanking frameworks while addressing ethical and governance concerns. His research shows strong international collaboration across multiple institutions and disciplines.

Mann's work has received significant attention beyond academia, with media coverage and substantial social media engagement. His research on promoting innovation and regulating generative AI in health sectors was widely shared across platforms including X (formerly Twitter) and Bluesky, with considerable academic readership on platforms like Mendeley.